Our Research and Development team, located in Israel, is authorized to carry out scientific and clinical studies on cannabinoid formulations. We are focused on thorough research the creation of cannabinoid-based therapies aimed at patients dealing with complex chronic eye conditions, including blepharitis,ibomian gland dysfunction, and dry eye. We are dedicated to advancing the next generation of eye treatments utilizing cannabinoids. These innovative, patent-pending cannabinoid therapies offer a new solution for various eye conditions that are not adequately treated at.